2017 American Transplant Congress Archives - Page 22 of 181

Validation of CYP4F11 as a Marker of Accommodation in Biopsies from Recipients of an ABO-Incompatible Renal Transplant.

K. Dominy,¹ M. Willicombe,³ T. Al Johani,² J. Galliford,³ A. McLean,³ T. Cook,³ C. Roufosse.³
Validation of a Novel Computational Approach for Predicting HLA Immunogenicity Based on Quantification of Structural and Surface Electrostatic Potential Differences Between Donor and Recipient HLA.

V. Kosmoliaptsis,¹ C. Kling,² M. Robb,³ D. Collett,³ J. Bradley,¹ C. Taylor,¹ D. Kabelitz,² D. Mallon.¹
Validation of a Prediction Model for Cardiac Allograft Vasculopathy.

E. Kransdorf, T. Aintablian, M. Kittleson, J. Patel, J. Kobashigawa.
Vancomycin Prophylaxis for Prevention of Clostridium difficile Recurrence in Renal Transplant Patients.

L. Spliner,¹ J. Fose,¹ G. Leverson,² J. Smith,³ C. Saddler,³ M. Jorgenson.¹
Variability in Tacrolimus Concentrations Across Pediatric Solid Organ Transplants.

S. Min,¹ T. Daljevic,¹ O. Lee,¹ M.-E. Alary,⁶ F. Murdoch,⁵ R. Parekh,¹ V. Ng,¹ D. Hebert,¹ L. Hamiwka,² T. Blydt-Hansen,³ V. Phan,⁴ P. Birk,³ U. Allen,¹ S. Urschel,⁵ CNTRP POSITIVE Research Group, B. Foster,⁶ S. Mital.¹
Variables Associated with Liver Graft Utilization and 30-Day Failure: A Liver Graft Quality Index.

J. Tang,¹ M. Esfandiari,¹ A. Zarrinpar.²
Variations in Risk-Appetite Between UK Kidney Transplant Centres and Impact on Patient and Graft Outcomes.

P. Trotter,^1,2 M. Robb,² D. Summers,^1,2 J. Bradley,¹ J. Neuberger,^2,4 C. Callaghan.^2,3
Vascularized Bone Marrow Mechanisms of Immunomodulation.

A. Khalifeh, E. Buckingham, M. Uluer, W. Hassanein, W. Twaddell, C. Drachenberg, A. Nam, S. Bartlett, R. Barth.
Vendor to Center in 0-60: A Cost-Effective Blueprint for Creating an In-House On-Call System for Abdominal Organ Offers.

J. Davenport, D. Cassidy, A. Hauser, A. Milling, K. Driggers, H. Crego, J. Anderson, L. Curry, P. Baliga, N. Pilch, D. Dubay.
Vendor to Center in 0-60: A Safe and Effective Blueprint for Creating an In-House On-Call System for Organ Offers.

K. Driggers, J. Davenport, D. Cassidy, L. Curry, A. Milling, A. Hauser, H. Crego, P. Baliga, N. Pilch, D. Dubay, J. Anderson.
Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients.

N. Lam,¹ A. Garg,² G. Knoll,³ J. Kim,⁴ K. Lentine,⁵ E. McArthur,⁶ K. Naylor,⁶ S. Bota,⁶ M. Sood.³
Very Long Term Graft Survival. Forecasts Factors.

S. Jimenez Alvaro, R. Marcen Letosa, A. Fernandez Rodriguez, S. Elias Treviño, C. Galeano Alvarez, F. Liaño Garcia.
Vimentin Regulates ß-Catenin Translocation During Epithelial to Mesenchymal Transition in Renal Fibrosis.

R. Lopez-Soler, Z. Wang, A. Divanyan.
Vital Role of the CoREST Complex as a Master Regulator of Foxp3+ T-Regulatory Cell Gene Expression and Suppressive Function.

L. Wang,¹ A. Samanta,¹ M. Levine,¹ U. Beier,¹ R. Han,¹ J. Kalin,² E. Holson,³ P. Cole,² W. Hancock.¹
VO_2peak: A Significant Marker of All-Cause Mortality Among Patients with End-Stage Renal Disease Being Evaluated for Kidney Transplant.

H. Chakkera,¹ M. Temkit,¹ B. Kaplan,¹ G. Gaesser,² R. Heilman,¹ H. Khamash,¹ K. Reddy,¹ E. Steidley,¹ A. Mathur,¹ S. Nair,¹ G. Mour,¹ J. Huskey,¹ A. Moss,¹ A. Singer,¹ W. Hewitt,¹ I. Qaqish,¹ S. Behmen,¹ S. Angadi.²

2017 American Transplant Congress

Validation of CYP4F11 as a Marker of Accommodation in Biopsies from Recipients of an ABO-Incompatible Renal Transplant.

Validation of a Novel Computational Approach for Predicting HLA Immunogenicity Based on Quantification of Structural and Surface Electrostatic Potential Differences Between Donor and Recipient HLA.

Validation of a Prediction Model for Cardiac Allograft Vasculopathy.

Vancomycin Prophylaxis for Prevention of Clostridium difficile Recurrence in Renal Transplant Patients.

Variability in Tacrolimus Concentrations Across Pediatric Solid Organ Transplants.

Variables Associated with Liver Graft Utilization and 30-Day Failure: A Liver Graft Quality Index.

Variations in Risk-Appetite Between UK Kidney Transplant Centres and Impact on Patient and Graft Outcomes.

Vascularized Bone Marrow Mechanisms of Immunomodulation.

Vendor to Center in 0-60: A Cost-Effective Blueprint for Creating an In-House On-Call System for Abdominal Organ Offers.

Vendor to Center in 0-60: A Safe and Effective Blueprint for Creating an In-House On-Call System for Organ Offers.

Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients.

Very Long Term Graft Survival. Forecasts Factors.

Vimentin Regulates ß-Catenin Translocation During Epithelial to Mesenchymal Transition in Renal Fibrosis.

Vital Role of the CoREST Complex as a Master Regulator of Foxp3+ T-Regulatory Cell Gene Expression and Suppressive Function.

VO_2peak: A Significant Marker of All-Cause Mortality Among Patients with End-Stage Renal Disease Being Evaluated for Kidney Transplant.